Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

DGX

QuestDiagnostics

NYSE

Real-time Quotes | Nasdaq Last Sale

138.95

+0.56

+0.40%

After Hours: 138.07 -0.88 -0.63% 17:14 05/07 EDT

OPEN

138.65

PREV CLOSE

138.39

HIGH

140.64

LOW

138.65

VOLUME

1.26M

TURNOVER

52 WEEK HIGH

140.64

52 WEEK LOW

103.26

MARKET CAP

18.15B

P/E (TTM)

10.54

Quest Diagnostics Inc. stock rises Friday, still underperforms market

marketwatch.com · 1h ago

Stocks That Hit 52-Week Highs On Friday

On Friday morning, 417 companies achieved new highs for the year.

Benzinga · 7h ago

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6)

Benzinga · 10h ago

Quest Diagnostics Inc. stock outperforms market on strong trading day

marketwatch.com · 1d ago

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5)

Benzinga · 1d ago

Drug Screening Market worth $10.0 billion by 2025 | Key Players are LabCorp (US), Quest Diagnostics (US)

May 05, 2021 (AB Digital via COMTEX) --  According to the new market research report "Drug Screening Market by Product (Consumables, Urine...

ABNewswire · 1d ago

Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains

Shares of Quest Diagnostics Inc. inched 0.13% higher to $136.57 Wednesday, on what proved to be an all-around positive trading session for the stock market,...

marketwatch.com · 2d ago

Weatherly Asset Management L. P. Buys Vanguard International Dividend Appreciation ETF, NextEra ...

GuruFocus News · 2d ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of DGX. Analyze the recent business situations of QuestDiagnostics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DGX stock price target is 143.60 with a high estimate of 158.00 and a low estimate of 130.00.

EPS

Institutional Holdings

Institutions: 1.09K

Institutional Holdings: 127.64M

% Owned: 97.71%

Shares Outstanding: 130.64M

TypeInstitutionsShares

Increased

283

7.60M

New

125

1.70M

Decreased

256

8.38M

Sold Out

1.70M

Performance
Asset Allocation
Dividend History

No Data

Industry

Healthcare Facilities & Services

+1.41%

Healthcare Providers & Services

+1.36%

Key Executives

Chairman/President/Chief Executive Officer/Director

Stephen Rusckowski

Chief Financial Officer/Executive Vice President

Mark Guinan

Executive Vice President

James Davis

Senior Vice President/General Counsel

Michael Prevoznik

Senior Vice President

Catherine Doherty

Senior Vice President

Carrie Manner

Lead Director/Independent Director

Daniel Stanzione

Independent Director

Vicky Gregg

Independent Director

Wright Lassiter

Independent Director

Timothy Main

Independent Director

Denise Morrison

Independent Director

Gary Pfeiffer

Independent Director

Timothy Ring

Independent Director

Helen Torley

Independent Director

Gail Wilensky

Declaration Date Dividend Per Share Ex-Div Date: 02/04/2021
Dividend USD 0.62
04/06/2021; 11/18/2020
Dividend USD 0.56
01/19/2021; 08/18/2020
Dividend USD 0.56
10/05/2020; 05/18/2020
Dividend USD 0.56
07/07/2020; 01/30/2020
Dividend USD 0.56
04/06/2020; 11/20/2019
Dividend USD 0.53
01/13/2020; 08/15/2019
Dividend USD 0.53
10/03/2019; 05/14/2019
Dividend USD 0.53
07/05/2019; 03/01/2019
Dividend USD 0.53
04/05/2019; 11/28/2018
Dividend USD 0.53
01/14/2019; 08/17/2018
Dividend USD 0.5
10/04/2018; 05/14/2018
Dividend USD 0.5
07/06/2018; 02/01/2018
Dividend USD 0.5
04/03/2018; 11/29/2017
Dividend USD 0.45
01/08/2018; 08/18/2017
Dividend USD 0.45
10/02/2017; 05/16/2017
Dividend USD 0.45
07/06/2017; 02/21/2017
Dividend USD 0.45
04/03/2017; 11/21/2016
Dividend USD 0.45
01/06/2017; 08/17/2016
Dividend USD 0.4
09/30/2016; 05/18/2016
Dividend USD 0.4
07/01/2016; 02/02/2016
Dividend USD 0.4
04/04/2016; 12/04/2015
Dividend USD 0.38
01/08/2016; 08/18/2015
Dividend USD 0.38
10/02/2015; 05/15/2015
Dividend USD 0.38
07/06/2015; 01/29/2015
Dividend USD 0.38
04/06/2015; 12/04/2014
Dividend USD 0.33
01/09/2015; 08/15/2014
Dividend USD 0.33
10/03/2014; 05/21/2014
Dividend USD 0.33
07/07/2014; 01/30/2014
Dividend USD 0.33
04/04/2014; 12/06/2013
Dividend USD 0.3
01/03/2014; 08/20/2013
Dividend USD 0.3
09/27/2013; 05/21/2013
Dividend USD 0.3
06/28/2013

All
Financials
Insiders

About DGX

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Webull offers kinds of Quest Diagnostics Inc stock information, including NYSE:DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.